HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7 | -12.5% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8 | -20.0% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $10 | -37.5% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $16 | -99.9% | 6,500 | 0.0% | 0.00% | -75.0% |
| Q3 2022 | $27,000 | +50.0% | 6,500 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $18,000 | -51.4% | 6,500 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $37,000 | -37.3% | 6,500 | 0.0% | 0.00% | -42.9% |
| Q4 2021 | $59,000 | -15.7% | 6,500 | 0.0% | 0.01% | -22.2% |
| Q3 2021 | $70,000 | -30.7% | 6,500 | 0.0% | 0.01% | -40.0% |
| Q2 2021 | $101,000 | – | 6,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |